Perfusion and metabolic scintigraphy with (123)I-BMIPP in prognosis of cardiac resynchronization therapy in patients with dilated cardiomyopathy.

about

Highlights of articles published in annals of nuclear medicine 2016.Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging.

P2860

Q45970536-2516B4B9-4861-42BB-9DDC-6D289BB4D834 Q52964188-0BC14469-899A-4058-AB7C-4694FA5B25B3

P2860

Perfusion and metabolic scintigraphy with (123)I-BMIPP in prognosis of cardiac resynchronization therapy in patients with dilated cardiomyopathy.

Item

http://www.wikidata.org/entity/Q40000681

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Perfusion and metabolic scinti ...... s with dilated cardiomyopathy.

@en

type

Item

label

Perfusion and metabolic scinti ...... s with dilated cardiomyopathy.

@en

prefLabel

Perfusion and metabolic scinti ...... s with dilated cardiomyopathy.

@en

P1476

Perfusion and metabolic scinti ...... ts with dilated cardiomyopathy

@en

P2093

Denis I Lebedev

http://www.w3.org/2001/XMLSchema#string

P2860

Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosis

Dyssynchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the Speckle Tracking and Resynchronization (STAR) study.

Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Cardiac resynchronization therapy for heart failure.

Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questions.

Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop.

The possible role of nuclear imaging in assessment of the cardiac resynchronization therapy effectiveness in patients with moderate heart failure.

The amount of viable and dyssynchronous myocardium is associated with response to cardiac resynchronization therapy: initial clinical results using multiparametric ECG-gated [18F]FDG PET.

Accuracy of 64-MDCT in the diagnosis of ischemic heart disease.

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

P2888

s12149-016-1064-0

P304

325-333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12149-016-1064-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Y B Lishmanov

K V Zavadovskiĭ

Marina O Gulya

P577

2016-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

294289427

http://www.w3.org/2001/XMLSchema#string

P6179

1037031628

http://www.w3.org/2001/XMLSchema#string

P698

26872805

http://www.w3.org/2001/XMLSchema#string

Perfusion and metabolic scintigraphy with (123)I-BMIPP in prognosis of cardiac resynchronization therapy in patients with dilated cardiomyopathy.

about

P2860

P2860

Perfusion and metabolic scintigraphy with (123)I-BMIPP in prognosis of cardiac resynchronization therapy in patients with dilated cardiomyopathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698